Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1/STAT6 pathways

Yunnan Lu,Mingming Zhou,Yun Li,Yan Li,Ye Hua,Yi Fan
DOI: https://doi.org/10.1016/j.bcp.2021.114464
IF: 6.1
2021-04-01
Biochemical Pharmacology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Increasing evidence suggests that microglia experience two distinct phenotypes after acute ischemic stroke (AIS): a deleterious M1 phenotype and a neuroprotective M2 phenotype. Promoting the phenotype shift of M1 microglia to M2 microglia is thought to improve functional recovery after AIS. Minocycline, a tetracycline antibiotic, can improve functional recovery after cerebral ischemia in pre-clinical and clinical research. However, the role and mechanisms of minocycline in microglia polarization is unclear.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Using the transient middle cerebral artery occlusion - reperfusion (MCAO/R) model, we treated mice with saline or different minocycline concentration (10, 25, or 50 mg/kg, i.p., daily for 2 wk) at 24 h after reperfusion. Neurobehavioral evaluation, rotarod test, and corner turning test were carried out on day 14 after reperfusion. Then, neuronal injury, reactive gliosis, and microglia polarization were performed on day 7 following MCAO/R. Finally, we treated primary microglial cultures with LPS (Lipopolysaccharide; 100 ng/mL) plus IFN-γ (20 ng/mL) 24 h to induce M1 phenotype and observed the effects of minocycline on the M1/M2-related mRNAs and the STAT1/STAT6 pathway.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We found that a 14-day treatment with minocycline increased the survival rate and promoted functional outcomes evaluated with neurobehavioral evaluation, rotarod test, and corner turning test. Meanwhile, minocycline reduced the brain infarct volume, alleviated neuronal injury, and suppressed reactive gliosis on day 7 following MCAO/R. Moreover, we observed an additive effect of minocycline on microglia polarization to the M1 and M2 phenotypes <em>in vivo</em> and <em>in vitro</em>. In the primary microglia, we further found that minocycline prevented neurons from OGD/R-induced cell death in neuron-microglia co-cultures via regulating M1/M2 microglia polarization through the STAT1/STAT6 pathway.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Minocycline promoted microglial M2 polarization and inhibited M1 polarization, leading to neuronal survival and neurological functional recovery. The findings deepen our understanding of the mechanisms underlying minocycline-mediated neuroprotection in AIS.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the specific mechanism by which minocycline promotes functional recovery after acute ischemic stroke (AIS) by regulating microglial cell polarization. Specifically, the research focuses on how minocycline promotes the transformation of microglial cells from the harmful M1 phenotype to the protective M2 phenotype by influencing the STAT1/STAT6 signaling pathway, thereby improving neurological function recovery after stroke and reducing brain damage. ### Research Background Acute ischemic stroke (AIS) is one of the leading causes of death and disability worldwide. Currently, the intravenous thrombolytic drug recombinant tissue - type plasminogen activator (IV - tPA) is the only thrombolytic drug approved for the treatment of AIS. However, some clinical trials have found that even with successful reperfusion, the damaged tissue may not be salvaged. Therefore, effective stroke - recovery drugs remain an important part of future stroke care. ### The Role of Microglial Cells Microglial cells, as the first line of defense in the brain, play a crucial role in the inflammatory response and repair process after stroke. Microglial cells can exhibit two different phenotypes: - **M1 Phenotype**: Stimulated by lipopolysaccharide (LPS) and interferon - γ (IFN - γ), it promotes the inflammatory response and aggravates brain damage. - **M2 Phenotype**: Stimulated by interleukin - 4 (IL - 4), it has a neuroprotective effect and promotes the repair process. ### The Role of Minocycline Minocycline is a tetracycline - class antibiotic known for its anti - inflammatory effects, especially in neurological diseases. Previous studies have shown that minocycline can prevent the activation of microglial cells and inhibit the activation of the NLRP3 inflammasome. Therefore, researchers hypothesized that minocycline may promote functional recovery after stroke by regulating the polarization of microglial cells from the M1 phenotype to the M2 phenotype. ### Research Methods The researchers used a transient middle cerebral artery occlusion - reperfusion (MCAO/R) model and conducted a series of experiments on mice, including: - **Behavioral Assessment**: Neurological behavior score, rotarod test, and corner - turning test. - **Histological Analysis**: TTC staining to assess the volume of cerebral infarction, immunohistochemistry to detect neuronal damage and microglial cell activation. - **Molecular Biology Analysis**: qRT - PCR to detect the expression of related genes, ELISA to detect cytokine levels, and Western blot to analyze protein expression. ### Main Results - **Functional Recovery**: Minocycline significantly increased the survival rate and improved the performance in neurological behavior score, rotarod test, and corner - turning test. - **Neuroprotective Effect**: Minocycline reduced the volume of cerebral infarction, alleviated neuronal damage and glial cell reaction. - **Microglial Cell Polarization**: Minocycline promoted the transformation of microglial cells from the M1 phenotype to the M2 phenotype by regulating the STAT1/STAT6 signaling pathway. ### Conclusion Minocycline enhances neuronal survival and neurological function recovery by promoting M2 polarization and inhibiting M1 polarization of microglial cells. These findings deepen our understanding of the mechanism by which minocycline exerts a neuroprotective effect in AIS.